Skip to main content

Table 3 A list of few vaccines that completed clinical trial phase 3

From: SARS-CoV-2 infection: a global outbreak and its implication on public health

Vaccine name

Research name

Vaccine type

Manufacturer

Country of origin

Side effects

Efficacy

References

Comirnaty

BNT162b2

3 LNP-mRNAs

Pfizer, BioNTech, Fosun Pharma

Multinational

Fatigue, headache, myalgia, chills, arthralgia

95%

Jeff Craven (2021), Kashte et al. (2021)

Moderna COVID-19 vaccine

Mrna-1273

LNP-encapsulated mRNA

Moderna, BARDA, NIAID

US

Tiredness, headache, muscle pain, chills, fever, nausea

94%

Jeff Craven (2021), Kashte et al. (2021)

AstraZeneca also known as Vaxzevria and Covishield

AZD1222

Non-replicating viral vector ChAdOx1-S

BARDA, OWS

UK

Tiredness, headache, muscle pain, chills, fever, nausea

70%

Kashte et al. (2021), Jeff Craven (2021)

Sputnik V

 

Non-replicating viral vector

Gamaleya research institute, Acellena contract drug research and development

Russia

Breathing difficulties, convulsions, swelling muscle weakness, high BP, headaches, dizziness

92%

Kashte et al. (2021), Jeff Craven (2021)

Janssen

JNJ-78436735; Ad26.COV2.S

Non-replicating viral vector

Janssen vaccines (Johnson & Johnson)

The Netherlands, US

Headache, fever, fatigue, muscle aches, nausea, irritation, redness

68%

Kashte et al. (2021), Jeff Craven (2021)

CoronaVac

 

Inactivated vaccine (formalin with alum adjuvant)

Sinovac

China

Rash, headache, muscle pain, fever, nausea, vomiting, injection site pain, fatigue

78%

Kashte et al. (2021), Jeff Craven (2021)

Sinopharm

BBIBP-CorV

Inactivated vaccine

Beijing institute of biological products; China national pharmaceutical group (Sinopharm)

China

Lethargy, drowsiness, difficulty sleeping, sneezing, nasopharyngitis, nasal congestion

86%

Kashte et al. (2021), Jeff Craven (2021)

EpiVacCorona

 

Peptide vaccine

Federal budgetary research institution state research center of virology and biotechnology

Russia

Jeff Craven (2021)

Convidicea

Ad5-nCoV

Recombinant vaccine (adenovirus type 5 vector)

CanSino Biologics

China

Fever, pain, swelling, sensitivity, fatigue, pain in muscles, joints and heads

66%

Kashte et al. (2021), Jeff Craven (2021)

Covaxin

BBV152

Inactivated vaccine

Bharat Biotech, ICMR; Ocugen

India

Pain, headache, fatigue, fever, body ache, abdominal pain, nausea, tremor, sweating, cold, cough

78%

Kashte et al. (2021), Jeff Craven (2021)

WIBP-CorV

 

Inactivated vaccine

Wuhan institute of biological products; China national pharmaceutical group (Sinopharm)

China

Rash, headache, muscle pain, fever, nausea, vomiting, injection site pain

72,51%

Jeff Craven (2021)

CoviVac

 

Inactivated vaccine

Chumakov Federal scientific center for research and development of immune and biological products

Russia

Jeff Craven (2021)

 

ZF2001

Recombinant vaccine

Anhui Zhifei Longcom biopharmaceutical institute of microbiology of the Chinese academy of sciences

China, Uzbekistan

Injection pain, redness, swelling

-

Jeff Craven (2021)

QazVac (QazCovid-in)

 

Inactivated vaccine

Research institute for biological safety problems

Kazakhstan

Jeff Craven (2021)

Novavax

NVX-Cov2373

Recombinant nanoparticle

Biofabri in Spain, FUJIFILM Diosynth Biotechnologies (FDB) in both North Carolina and Texas in the US, FDB in the UK, SIIPL in India, SK Bioscience in the Republic of Korea, Takeda Pharmaceutical Company Limited in Japan

UK & South Africa

Rash, headache, muscle pain, fever, nausea, vomiting, injection site pain

89.3%

Novavax (2021)